XENE Annual Long Term Debt
$9.60 M
-$343.00 K-3.45%
31 December 2023
Summary:
As of January 21, 2025, XENE annual long term debt is $9.60 million, with the most recent change of -$343.00 thousand (-3.45%) on December 31, 2023. During the last 3 years, it has risen by +$6.55 million (+214.89%). XENE annual long term debt is now -36.03% below its all-time high of $15.01 million, reached on December 31, 2018.XENE Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XENE Quarterly Long Term Debt
$8.40 M
-$280.00 K-3.23%
30 September 2024
Summary:
As of January 21, 2025, XENE quarterly long term debt is $8.40 million, with the most recent change of -$280.00 thousand (-3.23%) on September 30, 2024. Over the past year, it has dropped by -$280.00 thousand (-3.23%). XENE quarterly long term debt is now -47.05% below its all-time high of $15.86 million, reached on March 31, 2019.XENE Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XENE Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -3.5% | -3.2% |
| 3 y3 years | +214.9% | -18.3% |
| 5 y5 years | -36.0% | -18.3% |
XENE Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -3.5% | +25.5% | -19.5% | +17.4% |
| 5 y | 5-year | -17.4% | +214.9% | -27.8% | +4367.6% |
| alltime | all time | -36.0% | +476.8% | -47.0% | +4367.6% |
Xenon Pharmaceuticals Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $8.40 M(-3.2%) |
| June 2024 | - | $8.68 M(-4.6%) |
| Mar 2024 | - | $9.10 M(-5.2%) |
| Dec 2023 | $9.60 M(-3.4%) | $9.60 M(-1.6%) |
| Sept 2023 | - | $9.76 M(-5.1%) |
| June 2023 | - | $10.28 M(-1.4%) |
| Mar 2023 | - | $10.43 M(+4.9%) |
| Dec 2022 | $9.95 M(+30.0%) | $9.95 M(+39.0%) |
| Sept 2022 | - | $7.16 M(-8.8%) |
| June 2022 | - | $7.85 M(-4.5%) |
| Mar 2022 | - | $8.22 M(+7.5%) |
| Dec 2021 | $7.65 M | $7.65 M(+199.1%) |
| Sept 2021 | - | $2.56 M(-6.8%) |
| June 2021 | - | $2.75 M(-5.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $2.90 M(-4.9%) |
| Dec 2020 | $3.05 M(-73.8%) | $3.05 M(+1522.3%) |
| Sept 2020 | - | $188.00 K(-41.8%) |
| June 2020 | - | $323.00 K(-40.3%) |
| Mar 2020 | - | $541.00 K(-95.3%) |
| Dec 2019 | $11.63 M(-22.5%) | $11.63 M(-8.0%) |
| Sept 2019 | - | $12.64 M(-8.2%) |
| June 2019 | - | $13.78 M(-13.2%) |
| Mar 2019 | - | $15.86 M(+5.6%) |
| Dec 2018 | $15.01 M(+146.0%) | $15.01 M(+0.9%) |
| Sept 2018 | - | $14.89 M(+27.0%) |
| June 2018 | - | $11.72 M(+114.0%) |
| Mar 2018 | - | $5.48 M(-10.3%) |
| Dec 2017 | $6.10 M(+266.6%) | $6.10 M |
| Dec 2012 | $1.67 M | - |
FAQ
- What is Xenon Pharmaceuticals annual long term debt?
- What is the all time high annual long term debt for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals annual long term debt year-on-year change?
- What is Xenon Pharmaceuticals quarterly long term debt?
- What is the all time high quarterly long term debt for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals quarterly long term debt year-on-year change?
What is Xenon Pharmaceuticals annual long term debt?
The current annual long term debt of XENE is $9.60 M
What is the all time high annual long term debt for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high annual long term debt is $15.01 M
What is Xenon Pharmaceuticals annual long term debt year-on-year change?
Over the past year, XENE annual long term debt has changed by -$343.00 K (-3.45%)
What is Xenon Pharmaceuticals quarterly long term debt?
The current quarterly long term debt of XENE is $8.40 M
What is the all time high quarterly long term debt for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high quarterly long term debt is $15.86 M
What is Xenon Pharmaceuticals quarterly long term debt year-on-year change?
Over the past year, XENE quarterly long term debt has changed by -$280.00 K (-3.23%)